KUROBE PHARMACEUTICALS, INC. — Form D
KUROBE PHARMACEUTICALS, INC. of TAMPA, FL, a company, filed a Form D exempt-offering notice with the SEC on 2013-06-04. The offering totals $6.0M, of which $5.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2013-06-04
- Form: D
- Accession: 0001578486-13-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $6.0M
- Amount sold: $5.0M
- Remaining: $1.0M
- Minimum investment: $1
- Investors: 3
- Date of first sale: 2013-05-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-197424
Issuer
- Name: KUROBE PHARMACEUTICALS, INC.
- CIK: 0001578486
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 400 N ASHLEY DRIVE, TAMPA, FL, 33602
- Phone: 813-579-2550
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Barry Butler | Director | Tampa, FL |
| Sean Ianchulev | Director | San Mateo, CA |
| Eiji Katayama | Director | Osaka, M0 |
| Curt LaBelle | Director | Cambridge, MA |
| Naohito Takahashi | Director | Osaka, M0 |
| Barry Butler | Executive Officer | Tampa, FL |
| Haley Butler | Executive Officer | Tampa, FL |
| Yvonne Gallimore | Executive Officer | Tampa, FL |
More